Evidence map›Paper›PMID 36972613›Full record

ArticleSeminars in neurology2023

Dystonias: Clinical Recognition and the Role of Additional Diagnostic Testing.

Christopher D Stephen, Marisela Dy-Hollins, Claudio Melo De Gusmao, Xena Al Qahtani, Nutan Sharma

Abstract read
In one paragraph

Article in Seminars in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Functional dystonia in a guitarist: diagnostic challenges and clinical reflections.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher D StephenDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Marisela Dy-HollinsDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Claudio Melo De GusmaoDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts.
Xena Al QahtaniDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts.
Nutan SharmaDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusetts.

Funding

Clinical Trial Readiness In X-Linked Dystonia Parkinsonism: Assessment of Sensor-Based And Blood Biomarkers for Early Detection and Monitoring Disease ProgressionK23NS118045 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI STEPHEN, CHRISTOPHER D · 2021 to 2025
$1.1M
NINDS NIH HHS K23 NS118045
6 · The paper itself

Abstract

Dystonia is the third most common movement disorder, characterized by abnormal, frequently twisting postures related to co-contraction of agonist and antagonist muscles. Diagnosis is challenging. We provide a comprehensive appraisal of the epidemiology and an approach to the phenomenology and classification of dystonia, based on the clinical characteristics and underlying etiology of dystonia syndromes. We discuss the features of common idiopathic and genetic forms of dystonia, diagnostic challenges, and dystonia mimics. Appropriate workup is based on the age of symptom onset, rate of progression, whether dystonia is isolated or combined with another movement disorder or complex neurological and other organ system features. Based on these features, we discuss when imaging and genetic should be considered. We discuss the multidisciplinary treatment of dystonia, including rehabilitation and treatment principles according to the etiology, including when pathogenesis-direct treatment is available, oral pharmacological therapy, chemodenervation with botulinum toxin injections, deep brain stimulation and other surgical therapies, and future directions.

Indexed as

DystoniaDystonic DisordersDiagnostic Techniques and ProceduresHumansMuscles

Identifiers

PMID36972613
PMCPMC10240845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.